Advertisement

Topics

Varian Announces New VP of Investor Relations

04:07 EDT 10 Aug 2017 | PR Newswire

PALO ALTO, Calif., Aug. 10, 2017 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced it has named J. Michael Bruff as Vice President of Investor Relations effective August 7, 2017.  Mr. Bruff, 48, replaced Spencer Sias who retired in June 2017.

Mr. Bruff served Dell for 19 years in both domestic and international roles, most recently as Senior Vice President of North America Sales Strategy & Planning. Previously he served as Senior Vice President and CFO of Dell's Asia Pacific and Japan Commercial Business and Vice President of the Greater China Commercial Business.  He also held executive and leadership roles in financial planning & analysis, internal audit and Enterprise Solutions Group finance.  In addition, Mr. Bruff was Vice President, Global Services Accounting and Finance at CA, Inc. and held a variety of Finance and Accounting roles at MCI Telecommunications and Deloitte & Touche.

Mr. Bruff earned his Bachelor of Arts in Economics and Bachelor of Science in Accounting from the University of Maryland in 1990 and 1992, respectively.

About Varian Medical Systems
Varian Medical Systems focuses energy on saving lives and is the world's leading manufacturer of medical devices and software for treating and managing cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,600 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

Press Contact

Mark Plungy
Varian Medical Systems
+1 (650) 424-5630
mark.plungy@varian.com

Investor ContactMike Bruff
Varian Medical Systems
+1 (650) 424-5163
mike.bruff@varian.com

View original content:http://www.prnewswire.com/news-releases/varian-announces-new-vp-of-investor-relations-300502309.html

SOURCE Varian Medical Systems

NEXT ARTICLE

More From BioPortfolio on "Varian Announces New VP of Investor Relations"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...